NDAQ:MNPR - Post Discussion
Post by
whytestocks on Apr 16, 2024 8:45pm
Monopar Announces Filing of Patent Protecting MNPR-101 Radio
Just In: $MNPR Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization FindingsWILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that it has filed a provisional patent application pertaining to the recent adva...
MNPR - Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Be the first to comment on this post